Scandion Oncology: Initial reaction to CORIST phase II interim results

Research Note

2021-06-24

09:55

Redeye gives its initial impressions about Scandion’s release of positive CORIST phase II interim results. Following the scheduled audiocast at 10 am, we will come back with a more detailed note later today.

CB

Christian Binder

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.